Total Payments
$1,149
2024 Payments
$297.37
Companies
7
Transactions
43
Medicare Patients
971
Medicare Billing
$201,963
Payment Breakdown by Category
Food & Beverage$1,149 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,149 | 43 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $485.53 | 23 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $407.69 | 12 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $87.90 | 3 | $0 (2023) |
| PORTOLA PHARMACEUTICALS, INC. | $87.50 | 1 | $0 (2019) |
| Allergan Inc. | $40.28 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $24.55 | 1 | $0 (2018) |
| Medtronic Vascular, Inc. | $15.64 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $297.37 | 14 | PFIZER INC. ($225.70) |
| 2023 | $201.19 | 9 | PFIZER INC. ($93.52) |
| 2022 | $72.02 | 2 | PFIZER INC. ($72.02) |
| 2021 | $39.54 | 2 | PFIZER INC. ($39.54) |
| 2020 | $40.83 | 2 | PFIZER INC. ($40.83) |
| 2019 | $226.41 | 3 | Janssen Pharmaceuticals, Inc ($124.99) |
| 2018 | $130.54 | 6 | Janssen Pharmaceuticals, Inc ($50.67) |
| 2017 | $141.19 | 5 | Janssen Pharmaceuticals, Inc ($78.40) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/23/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/21/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/03/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/05/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/09/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/12/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/01/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/08/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/11/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/28/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/15/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/18/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/10/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $36.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/26/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Rare Disease | ||||||
| 08/11/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $39.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/28/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $32.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 258 | 705 | $200,873 | $52,859 |
| 2022 | 5 | 218 | 582 | $170,190 | $40,948 |
| 2021 | 5 | 243 | 660 | $194,710 | $46,781 |
| 2020 | 4 | 252 | 773 | $240,212 | $61,374 |
Total Patients
971
Total Services
2,720
Medicare Billing
$201,963
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 214 | 661 | $182,461 | $48,408 | 26.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $12,792 | $2,937 | 23.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 20 | 20 | $5,620 | $1,514 | 26.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 159 | 520 | $143,540 | $34,735 | 24.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $9,580 | $2,202 | 23.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 18 | $7,146 | $1,686 | 23.6% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $5,709 | $1,299 | 22.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 14 | 15 | $4,215 | $1,026 | 24.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 161 | 556 | $153,456 | $36,712 | 23.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 32 | 50 | $19,850 | $4,899 | 24.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 24 | 25 | $13,325 | $3,257 | 24.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 15 | 15 | $4,215 | $1,004 | 23.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 11 | 14 | $3,864 | $909.30 | 23.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 103 | 291 | $110,631 | $28,356 | 25.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 111 | 404 | $108,000 | $27,643 | 25.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 27 | 28 | $14,374 | $3,485 | 24.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 11 | 50 | $7,207 | $1,890 | 26.2% |
About Dr. Arif Mumtaz, MD
Dr. Arif Mumtaz, MD is a Internal Medicine healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093736472.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arif Mumtaz, MD has received a total of $1,149 in payments from pharmaceutical and medical device companies, with $297.37 received in 2024. These payments were reported across 43 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,149).
As a Medicare-enrolled provider, Mumtaz has provided services to 971 Medicare beneficiaries, totaling 2,720 services with total Medicare billing of $201,963. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Valhalla, NY
- Active Since 07/21/2006
- Last Updated 02/29/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1093736472
Products in Payments
- ELIQUIS (Drug) $468.75
- XARELTO (Drug) $392.33
- ANDEXXA (Biological) $87.50
- SOLIRIS (Drug) $62.19
- TEFLARO (Drug) $26.25
- ULTOMIRIS (Biological) $25.71
- ENTRESTO (Drug) $24.55
- VYNDAQEL (Drug) $16.78
- Reveal LINQ (Device) $15.64
- INVOKANA (Drug) $15.36
- AVYCAZ (Drug) $14.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Valhalla
Dr. Jay Doshi, M.d, M.D
Internal Medicine — Payments: $96,684
Internal Medicine $96,684
Luciano De Marco, M.d, M.D
Internal Medicine — Payments: $14,149
Internal Medicine $14,149
Neal Shah, M.d, M.D
Internal Medicine — Payments: $5,403
Internal Medicine $5,403
Sade Solola Nussbaum, Md, MD
Internal Medicine — Payments: $4,024
Internal Medicine $4,024
Rhonda Rubin, Md, MD
Internal Medicine — Payments: $2,982
Internal Medicine $2,982
Adrese Kandahari, M.d, M.D
Internal Medicine — Payments: $2,880
Internal Medicine $2,880